Curcumin treatment provides protection against Trypanosoma cruzi infection
Parasitology Research - 2012
Tóm tắt
Trypanosoma cruzi, the etiologic agent of Chagas disease, causes an acute myocarditis and chronic cardiomyopathy. The current therapeutic agents for this disease are not always effective and often have severe side effects. Curcumin, a plant polyphenol, has demonstrated a wide range of potential therapeutic effects. In this study, we examined the effect of curcumin on T. cruzi infection in vitro and in vivo. Curcumin pretreatment of fibroblasts inhibited parasite invasion. Treatment reduced the expression of the low density lipoprotein receptor, which is involved in T. cruzi host cell invasion. Curcumin treatment of T. cruzi-infected CD1 mice reduced parasitemia and decreased the parasitism of infected heart tissue. This was associated with a significant reduction in macrophage infiltration and inflammation in both the heart and liver; moreover, curcumin-treated infected mice displayed a 100% survival rate in contrast to the 60% survival rate commonly observed in untreated infected mice. These data are consistent with curcumin modulating infection-induced changes in signaling pathways involved in inflammation, oxidative stress, and apoptosis. These data suggest that curcumin and its derivatives could be a suitable drug for the amelioration of chagasic heart disease.
Từ khóa
Tài liệu tham khảo
Adesse D, Lisanti MP, Spray DC, Machado FS, de Nazareth MM, Tanowitz HB, Garzoni LR (2010) Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart. Cell Cycle 9(8):1639–1646
Aggarwal S, Kim SW, Cheon K, Tabassam FH, Yoon JH, Koo JS (2006) Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. Mol Biol Cell 17(2):566–575. doi:10.1091/mbc.E05-06-0519
Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR (1998) Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4(6):376–383
Ashton AW, Mukherjee S, Nagajyothi FN, Huang H, Braunstein VL, Desruisseaux MS, Factor SM, Lopez L, Berman JW, Wittner M, Scherer PE, Capra V, Coffman TM, Serhan CN, Gotlinger K, Wu KK, Weiss LM, Tanowitz HB (2007) Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med 204(4):929–940. doi:10.1084/jem.20062432
Chan WH, Wu HJ (2004) Anti-apoptotic effects of curcumin on photosensitized human epidermal carcinoma A431 cells. J Cell Biochem 92(1):200–212. doi:10.1002/jcb.20059
Chiu J, Khan ZA, Farhangkhoee H, Chakrabarti S (2009) Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition 25(9):964–972. doi:10.1016/j.nut.2008.12.007
Chuenkova MV, PereiraPerrin M (2009) Trypanosoma cruzi targets Akt in host cells as an intracellular antiapoptotic strategy. Sci Signal 2(97):ra74. doi:10.1126/scisignal.2000374
Combs TP, Nagajyothi MS, de Almeida CJ, Jelicks LA, Schubert W, Lin Y, Jayabalan DS, Zhao D, Braunstein VL, Landskroner-Eiger S, Cordero A, Factor SM, Weiss LM, Lisanti MP, Tanowitz HB, Scherer PE (2005) The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem 280(25):24085–24094. doi:10.1074/jbc.M412802200
Durand JL, Mukherjee S, Commodari F, De Souza AP, Zhao D, Machado FS, Tanowitz HB, Jelicks LA (2009) Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice. Am J Trop Med Hyg 80(5):782–787
Ghosh SS, Salloum FN, Abbate A, Krieg R, Sica DA, Gehr TW, Kukreja RC (2010) Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats. Am J Physiol Heart Circ Physiol 299(4):H975–H984. doi:10.1152/ajpheart.00154.2010
Gupta S, Wen JJ, Garg NJ (2009) Oxidative stress in Chagas disease. Interdiscip Perspect Infect Dis 2009:190354. doi:10.1155/2009/190354
Gutierrez FR, Lalu MM, Mariano FS, Milanezi CM, Cena J, Gerlach RF, Santos JE, Torres-Dueñas D, Cunha FQ, Schulz R, Silva JS (2008) Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J Infect Dis 197(10):1468–1476
Hendgen-Cotta UB, Merx MW, Shiva S, Schmitz J, Becher S, Klare JP, Steinhoff HJ, Goedecke A, Schrader J, Gladwin MT, Kelm M, Rassaf T (2008) Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia–reperfusion injury. Proc Natl Acad Sci U S A 105(29):10256–10261. doi:10.1073/pnas.0801336105
Heussler V, Sturm A, Langsley G (2006) Regulation of host cell survival by intracellular Plasmodium and Theileria parasites. Parasitology 132(Suppl):S49–S60. doi:10.1017/S0031182006000850
Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, Lee MJ, Yang CS (2004) Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25(9):1671–1679. doi:10.1093/carcin/bgh165
Kang Q, Chen A (2009a) Curcumin inhibits srebp-2 expression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1. Endocrinology 150(12):5384–5394. doi:10.1210/en.2009-0517
Kang Q, Chen A (2009b) Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells. Br J Pharmacol 157:1354–1367
Kuttan G, Kumar KB, Guruvayoorappan C, Kuttan R (2007) Antitumor, anti-invasion, and antimetastatic effects of curcumin. Adv Exp Med Biol 595:173–184
Li L, Ahmed B, Mehta K, Kurzrock R (2007) Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 6(4):1276–1282. doi:10.1158/1535-7163.MCT-06-0556
Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS (2000) Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102(24):3003–3008
Medina FA, Cohen AW, de Almeida CJ, Nagajyothi F, Braunstein VL, Teixeira MM, Tanowitz HB, Lisanti MP (2007) Immune dysfunction in caveolin-1 null mice following infection with Trypanosoma cruzi (Tulahuen strain). Microbes Infect 9(3):325–333. doi:10.1016/j.micinf.2006.12.011
Melo RC (2009) Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection. J Cell Mol Med 13(2):279–294. doi:10.1111/j.1582-4934.2008.00388.x
Nagajyothi F, Desruisseaux M, Bouzahzah B, Weiss LM, Andrade Ddos S, Factor SM, Scherer PE, Albanese C, Lisanti MP, Tanowitz HB (2006) Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis. Cell Cycle 5(1):107–112
Nagajyothi F, Desruisseaux MS, Thiruvur N, Weiss LM, Braunstein VL, Albanese C, Teixeira MM, de Almeida CJ, Lisanti MP, Scherer PE, Tanowitz HB (2008) Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity (Silver Spring) 16(9):1992–1997
Nagajyothi F, Zhao D, Machado FS, Weiss LM, Schwartz GJ, Desruisseaux MS, Zhao Y, Factor SM, Huang H, Albanese C, Teixeira MM, Scherer PE, Chua SC Jr, Tanowitz HB (2010) Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. J Infect Dis 202(7):1104–1113. doi:10.1086/656189
Nagajyothi F, Weiss LM, Silver DL, Desruisseaux MS, Scherer PE, Herz J, Tanowitz HB (2011) Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion. PLoS Negl Trop Dis 5(2):e953. doi:10.1371/journal.pntd.0000953
Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN (2005) Curcumin for malaria therapy. Biochem Biophys Res Commun 326(2):472–474
Romero EL, Morilla MJ (2010) Nanotechnological approaches against Chagas disease. Adv Drug Deliv Rev 62(4–5):576–588
Rowin KS, Tanowitz HB, Wittner M, Nguyen HT, Nadal-Ginard B (1983) Inhibition of muscle differentiation by trypanosoma cruzi. Proc Natl Acad Sci U S A 80(20):6390–6394
Tyler KM, Engman DM (2000) Flagellar elongation induced by glucose limitation is preadaptive for Trypanosoma cruzi differentiation. Cell Motil Cytoskeleton 46:269–278
Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, Brenner DE (2008) Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 17(6):1411–1417. doi:10.1158/1055-9965.EPI-07-2693
Wang Z, Nakayama T (2010) Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010:535918. doi:10.1155/2010/535918
Yuan HY, Kuang SY, Zheng X, Ling HY, Yang YB, Yan PK, Li K, Liao DF (2008) Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells. Acta Pharmacol Sin 29(5):555–563. doi:10.1111/j.1745-7254.2008.00783.x
Zhang L, Tarleton RL (1996) Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections. Exp Parasitol 84(2):203–213